期刊
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
卷 14, 期 5, 页码 944-957出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/gme.0b013e31802e8508
关键词
hormone therapy; statin therapy; cardiovascular disease; breast cancer; stroke; venous; thromboembolism
资金
- NIA NIH HHS [R01-AG24154] Funding Source: Medline
- NATIONAL INSTITUTE ON AGING [R01AG024154] Funding Source: NIH RePORTER
Although many of the risks and benefits of postmenopausal hormone therapy are known, only recently has the magnitude of these effects and their perspective to other therapies become more fully understood. Careful review of randomized controlled trials indicates that the risks of postmenopausal hormone therapy including breast cancer, stroke and venous thromboembolism are similar to other commonly used agents. Overall, these risks are rare (less than I event per 1,000 women) and even rarer when initiated in women less than 60 years of age or within 10 years of menopause. In addition, the literature indicates similar benefit of postmenopausal hormone therapy, in women who initiate hormone therapy in close proximity to menopause, to other medications used for the primary prevention of coronory heart disease in women.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据